Efmarodocokin alfa Reference: HY-P99919 Efmarodocokin alfa is a fusion protein of human IL-22 and the IgG4 crystallizable fragment. Efmarodocokin alfa activates IL-22 signaling. Efmarodocokin alfa can be used for the research of severe COVID-19 pneumonia.
CTX-2026 Reference: HY-P99179 CTX-2026 is a fully human antibody that binds to CD277. CTX-2026 shows an anti-tumor effect on ovarian tumor models. CTX-2026 can be used for the research of cancer.
Mitochondria/Caspase dependant Apoptosis Antibody Panel (Caspase3, Caspase9,... Reference: ARG30110 Mitochondria/Caspase dependant Apoptosis antibody; Caspase 3 antibody; Cytochrome C antibody; PARP (cleaved) antibody; Caspase 9 (cleaved) antibody
Tibulizumab Reference: HY-P99563 Tibulizumab (LY 3090106) is a tetravalent bispecific monoclonal antibody targeting B-cell activating factor (BAFF) and IL-17A with Kd values of 60 pM and 14 pM, respectively. Tibulizumab can be used for autoimmune disease research.
Suvratoxumab Reference: HY-P99583 Suvratoxumab (MEDI4893) is a long-acting, high-affinity humanized anti-α-toxin monoclonal antibody (IgG1κ type). Suvratoxumab potently neutralizes α-toxin, a key S. aureus virulence factor. Suvratoxumab improves survival and reduces lung injury in an immunocompromised mice model of pneumonia. Suvratoxumab also enhances the antibacterial activity of Vancomycin (HY-B0671) or Linezolid (HY-10394).
Spesolimab Reference: HY-P99396 Spesolimab (BI 655130) is an anti-IL-36R antibody. IL-36 involves in immune system, as Spesolimab can be used for palmoplantar pustulosis (PPP) research. Spesolimab is associated with the reduction of biomarkers linked to innate, Th1/Th17, and neutrophilic pathways.
Phospho c-Myc Antibody Panel (Total, pT58, pS62) Reference: ARG30126 Phospho c-Myc antibody; c-Myc antibody; Myc phospho (Thr58) antibody; Myc phospho (Ser62) antibody
Pimivalimab Reference: HY-P99887 Pimivalimab (JTX-4014) is a PD-1 inhibitor. Pimivalimab can be used for the research of solid tumor.